JP2024534963A5 - - Google Patents
Info
- Publication number
- JP2024534963A5 JP2024534963A5 JP2024515369A JP2024515369A JP2024534963A5 JP 2024534963 A5 JP2024534963 A5 JP 2024534963A5 JP 2024515369 A JP2024515369 A JP 2024515369A JP 2024515369 A JP2024515369 A JP 2024515369A JP 2024534963 A5 JP2024534963 A5 JP 2024534963A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- paste
- group
- small molecule
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163242405P | 2021-09-09 | 2021-09-09 | |
| US63/242,405 | 2021-09-09 | ||
| US202263351786P | 2022-06-13 | 2022-06-13 | |
| US63/351,786 | 2022-06-13 | ||
| PCT/US2022/076212 WO2023039531A1 (en) | 2021-09-09 | 2022-09-09 | Injectable high concentration pharmaceutical formulations and methods of manufacturing and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534963A JP2024534963A (ja) | 2024-09-26 |
| JP2024534963A5 true JP2024534963A5 (enExample) | 2025-09-17 |
Family
ID=83508409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024515369A Pending JP2024534963A (ja) | 2021-09-09 | 2022-09-09 | 注射可能な高濃度の薬学的製剤ならびにその製造および使用の方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230085357A1 (enExample) |
| EP (1) | EP4398874A1 (enExample) |
| JP (1) | JP2024534963A (enExample) |
| KR (1) | KR20240057428A (enExample) |
| AU (1) | AU2022343289A1 (enExample) |
| CA (1) | CA3231500A1 (enExample) |
| IL (1) | IL311336A (enExample) |
| MX (1) | MX2024002920A (enExample) |
| WO (1) | WO2023039531A1 (enExample) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE318580T1 (de) | 1996-12-20 | 2006-03-15 | Alza Corp | Gelzusammensetzungen und verfahren |
| US20050042194A1 (en) * | 2000-05-11 | 2005-02-24 | A.P. Pharma, Inc. | Semi-solid delivery vehicle and pharmaceutical compositions |
| EP1589901A4 (en) | 2002-12-20 | 2006-08-09 | Generipharm Inc | INTRAKUTANE INJECTION |
| US20040247672A1 (en) * | 2003-05-16 | 2004-12-09 | Alkermes Controlled Therapeutics, Inc. | Injectable sustained release compositions |
| SI2849723T1 (sl) * | 2012-05-18 | 2018-09-28 | Genentech, Inc. | Formulacije z visoko koncentracijo monoklonskih protiteles |
| WO2015120231A2 (en) | 2014-02-06 | 2015-08-13 | Xeris Phrmaceuticals, Inc. | Stable peptide formulations and methods for preparation |
| KR102428675B1 (ko) * | 2014-08-06 | 2022-08-02 | 엑스에리스 파머수티클스, 인크. | 페이스트의 피내 및／또는 피하 주사를 위한 주사기, 키트, 및 방법 |
| EA202191403A1 (ru) * | 2018-11-21 | 2021-08-09 | Ридженерон Фармасьютикалз, Инк. | Композиция с высокой концентрацией белка |
-
2022
- 2022-09-09 EP EP22783246.6A patent/EP4398874A1/en active Pending
- 2022-09-09 CA CA3231500A patent/CA3231500A1/en active Pending
- 2022-09-09 WO PCT/US2022/076212 patent/WO2023039531A1/en not_active Ceased
- 2022-09-09 KR KR1020247010815A patent/KR20240057428A/ko active Pending
- 2022-09-09 AU AU2022343289A patent/AU2022343289A1/en active Pending
- 2022-09-09 JP JP2024515369A patent/JP2024534963A/ja active Pending
- 2022-09-09 US US17/930,857 patent/US20230085357A1/en active Pending
- 2022-09-09 IL IL311336A patent/IL311336A/en unknown
- 2022-09-09 MX MX2024002920A patent/MX2024002920A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6771528B2 (ja) | 医薬組成物および関連する送達方法 | |
| ES2248070T3 (es) | Decetaxel en combinacioncon rhumab hr2 para el tratamiento de canceres. | |
| TWI725973B (zh) | 抗-ｃｇｒｐ抗體調配物 | |
| Shah et al. | Oral delivery of proteins: progress and prognostication | |
| RU2019125238A (ru) | Препараты антител против her2 для подкожного введения | |
| CA2794929A1 (en) | Concentrated protein formulations and uses thereof | |
| JP2020515519A5 (enExample) | ||
| WO2013177565A1 (en) | Insulin-pramlintide compositions and methods for making and using them | |
| US20240325417A1 (en) | Combination therapy for treatment of liver diseases | |
| US20110152192A1 (en) | Compositions and Methods for the Treatment of Angiogenesis-Related Eye Diseases | |
| US20240408179A1 (en) | Oral delivery of therapeutic agents | |
| EP3528828B1 (en) | Terlipressin composition for use in treating ascites | |
| US20170173110A1 (en) | Combination therapy for ameliorating adverse side effects caused by chemotherapy | |
| US20240207290A1 (en) | Cyclic phosphonate composition and preparation method thereof | |
| TW202317110A (zh) | 用於治療肝臟疾病的聯合治療 | |
| WO2024120513A1 (zh) | 口服多肽组合物及其用途 | |
| WO2024077409A1 (en) | Oral delivery of therapeutic agents | |
| CN116196424A (zh) | 蛋白转运抑制剂在制备用于治疗炎性骨吸收的药物中的用途 | |
| JP5860406B2 (ja) | 徐放性医薬組成物 | |
| CN101062406A (zh) | 重组人粒细胞集落刺激因子微乳 | |
| WO2025171378A1 (en) | Insulin receptor modulation for tumor associated hyperinsulinism | |
| KR20240057428A (ko) | 주사 가능한 고농도 약제학적 제형 및 이의 제조 및 사용 방법 | |
| KR20230025890A (ko) | 인터루킨-17(il-17) 길항제를 이용한 갑상선 안병증 및 그레이브스 안와병증의 치료 방법 | |
| RU2020113092A (ru) | Препараты антител против her2 для подкожного введения | |
| HK40120596A (en) | Terlipressin compositions and their methods of use |